These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 22139535)
21. In vitro schistosomicidal activity of the lignan (-)-6,6'-dinitrohinokinin (DNHK) loaded into poly(lactic-co-glycolic acid) nanoparticles against Schistosoma mansoni. Lima TC; Lucarini R; Luz PP; de Faria EH; Marçal L; Magalhães LG; Badoco FR; Esperandim VR; Molina EF; Laurentz RS; Lima RG; Cunha WR; Bastos JK; Silva MLA Pharm Biol; 2017 Dec; 55(1):2270-2276. PubMed ID: 29172838 [TBL] [Abstract][Full Text] [Related]
22. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration. Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882 [TBL] [Abstract][Full Text] [Related]
23. PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood-brain barrier. Fornaguera C; Dols-Perez A; Calderó G; García-Celma MJ; Camarasa J; Solans C J Control Release; 2015 Aug; 211():134-43. PubMed ID: 26057857 [TBL] [Abstract][Full Text] [Related]
24. Enhanced uptake and transport of PLGA-modified nanoparticles in cervical cancer. Sims LB; Curtis LT; Frieboes HB; Steinbach-Rankins JM J Nanobiotechnology; 2016 Apr; 14():33. PubMed ID: 27102372 [TBL] [Abstract][Full Text] [Related]
25. Ibuprofen delivered by poly(lactic-co-glycolic acid) (PLGA) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations. Bonelli P; Tuccillo FM; Federico A; Napolitano M; Borrelli A; Melisi D; Rimoli MG; Palaia R; Arra C; Carinci F Int J Nanomedicine; 2012; 7():5683-91. PubMed ID: 23180963 [TBL] [Abstract][Full Text] [Related]
26. Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells. Mitra M; Misra R; Harilal A; Sahoo SK; Krishnakumar S Mol Vis; 2011; 17():2724-37. PubMed ID: 22065926 [TBL] [Abstract][Full Text] [Related]
27. Targeted delivery of mannosylated-PLGA nanoparticles of antiretroviral drug to brain. Patel BK; Parikh RH; Patel N Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):97-100. PubMed ID: 29593405 [TBL] [Abstract][Full Text] [Related]
28. Elimination of mouse tumor cells from neonate spermatogonial cells utilizing cisplatin-entrapped folic acid-conjugated poly(lactic-co-glycolic acid) nanoparticles in vitro. Shabani R; Ashjari M; Ashtari K; Izadyar F; Behnam B; Khoei S; Asghari-Jafarabadi M; Koruji M Int J Nanomedicine; 2018; 13():2943-2954. PubMed ID: 29849458 [TBL] [Abstract][Full Text] [Related]
29. Poly(D,L-lactide-co-glycolide) nanoparticles encapsulated fluorescent isothiocyanate and paclitaxol: preparation, release kinetics and anticancer effect. Yang H; Li K; Liu Y; Liu Z; Miyoshi H J Nanosci Nanotechnol; 2009 Jan; 9(1):282-7. PubMed ID: 19441308 [TBL] [Abstract][Full Text] [Related]
30. Polymeric nanoparticles produced by electrohydrodynamic atomisation for the passive delivery of imatinib. Tsilova SL; Schreiber BE; Lever R; Parhizkar M Eur J Pharm Biopharm; 2024 Sep; 202():114412. PubMed ID: 39013491 [TBL] [Abstract][Full Text] [Related]
31. PLGA nanoparticles for the oral delivery of nuciferine: preparation, physicochemical characterization and in vitro/in vivo studies. Liu Y; Wu X; Mi Y; Zhang B; Gu S; Liu G; Li X Drug Deliv; 2017 Nov; 24(1):443-451. PubMed ID: 28165858 [TBL] [Abstract][Full Text] [Related]
32. Colon-targeted delivery of cyclosporine A using dual-functional Eudragit Naeem M; Bae J; Oshi MA; Kim MS; Moon HR; Lee BL; Im E; Jung Y; Yoo JW Int J Nanomedicine; 2018; 13():1225-1240. PubMed ID: 29535519 [TBL] [Abstract][Full Text] [Related]
33. Surface modification of poly(D,L-lactic-co-glycolic acid) nanoparticles using sodium carboxymethyl cellulose as colloidal stabilize. Chittasupho C; Thongnopkoon T; Kewsuwan P Curr Drug Deliv; 2016; 13(1):95-104. PubMed ID: 26338259 [TBL] [Abstract][Full Text] [Related]
34. Preparation, characterization, and safety evaluation of poly(lactide-co-glycolide) nanoparticles for protein delivery into macrophages. Guedj AS; Kell AJ; Barnes M; Stals S; Gonçalves D; Girard D; Lavigne C Int J Nanomedicine; 2015; 10():5965-79. PubMed ID: 26445538 [TBL] [Abstract][Full Text] [Related]
35. Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release. Yoo HS; Oh JE; Lee KH; Park TG Pharm Res; 1999 Jul; 16(7):1114-8. PubMed ID: 10450940 [TBL] [Abstract][Full Text] [Related]
36. Cell Line and Augument Cellular Uptake Study of Statistically Optimized Sustained Release Capecitabine Loaded Eudragit S100/PLGA(poly(lacticco- glycolic acid)) Nanoparticles for Colon Targeting. Pandey S; Vijayendra Swamy SM; Ubaid Ulla UM; Gupta A; Patel H; Yadav JS Curr Drug Deliv; 2017 Sep; 14(6):887-899. PubMed ID: 27538461 [TBL] [Abstract][Full Text] [Related]
37. Novel PLGA-based nanoparticles for the oral delivery of insulin. Malathi S; Nandhakumar P; Pandiyan V; Webster TJ; Balasubramanian S Int J Nanomedicine; 2015; 10():2207-18. PubMed ID: 25848248 [TBL] [Abstract][Full Text] [Related]
38. Efficacy of piroxicam plus cisplatin-loaded PLGA nanoparticles in inducing apoptosis in mesothelioma cells. Menale C; Piccolo MT; Favicchia I; Aruta MG; Baldi A; Nicolucci C; Barba V; Mita DG; Crispi S; Diano N Pharm Res; 2015 Feb; 32(2):362-74. PubMed ID: 25092068 [TBL] [Abstract][Full Text] [Related]
39. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir. Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964 [TBL] [Abstract][Full Text] [Related]
40. In vitro evaluation of 5-aminolevulinic acid (ALA) loaded PLGA nanoparticles. Shi L; Wang X; Zhao F; Luan H; Tu Q; Huang Z; Wang H; Wang H Int J Nanomedicine; 2013; 8():2669-76. PubMed ID: 23926429 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]